(Q46681659)

English

Results of 58872 and 58921 trials in acute myeloblastic leukemia and relative value of chemotherapy vs allogeneic bone marrow transplantation in first complete remission: the EORTC Children Leukemia Group report

scientific article published in December 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16136166

Results of 58872 and 58921 trials in acute myeloblastic leukemia and relative value of chemotherapy vs allogeneic bone marrow transplantation in first complete remission: the EORTC Children Leukemia Group report (English)

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16136166

1 reference

based on heuristic

inferred from title

Acute myeloblastic leukemia

1 reference

based on heuristic

inferred from title

author name string

N Entz-Werle

1

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16136166

S Suciu

2

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16136166

J van der Werff ten Bosch

3

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16136166

E Vilmer

4

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16136166

Y Bertrand

5

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16136166

Y Benoit

6

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16136166

G Margueritte

7

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16136166

E Plouvier

8

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16136166

P Boutard

9

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16136166

E Vandecruys

10

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16136166

A Ferster

11

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16136166

P Lutz

12

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16136166

A Uyttebroeck

13

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16136166

C Hoyoux

14

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16136166

A Thyss

15

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16136166

X Rialland

16

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16136166

L Norton

17

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16136166

M-P Pages

18

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16136166

N Philippe

19

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16136166

J Otten

20

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16136166

C Behar

21

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16136166

EORTC Children Leukemia Group

22

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16136166

publication date

1 December 2005

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16136166

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16136166

19

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16136166

12

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16136166

2072-2081

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16136166

https://scigraph.springernature.com/pub.10.1038/sj.leu.2403932

0 references

Salvage treatment for primary resistant acute myelogenous leukemia consisting of intermediate-dose cytosine arabinoside and interspaced continuous infusions of idarubicin: a phase-II study (no. 06901) of the EORTC Leukemia Cooperative Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403932

21 January 2018

Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403932

21 January 2018

Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML 10 trial. UK Medical Research Council Adult and Children's Leukaemia Working Par

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403932

21 January 2018

Prognostic variables in newly diagnosed children and adolescents with acute myeloid leukemia: Children's Cancer Group Study 213.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403932

21 January 2018

Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403932

21 January 2018

Favorable impact of the t(9;11) in childhood acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403932

21 January 2018

Mitoxantrone-containing regimen for treatment of childhood acute leukemia (AML) and analysis of prognostic factors: results of the EORTC Children Leukemia Cooperative Study 58872

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403932

7 January 2021

based on heuristic

inferred from DOI database lookup

Intensively timed induction therapy followed by autologous or allogeneic bone marrow transplantation for children with acute myeloid leukemia or myelodysplastic syndrome: a Childrens Cancer Group pilot study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403932

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose cytarabine and daunorubicin as consolidation therapy for acute myeloid leukemia in first remission: long-term follow-up and results

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403932

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose cytarabine for intensification of early therapy of childhood acute myeloid leukemia: a Pediatric Oncology Group study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403932

7 January 2021

based on heuristic

inferred from DOI database lookup

Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML-MO)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403932

7 January 2021

based on heuristic

inferred from DOI database lookup

The stem cell mobilizing capacity of patients with acute myeloid leukemia in complete remission correlates with relapse risk: results of the EORTC-GIMEMA AML-10 trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403932

7 January 2021

based on heuristic

inferred from DOI database lookup

Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403932

7 January 2021

based on heuristic

inferred from DOI database lookup

Pediatric acute myeloid leukemia: international progress and future directions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403932

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved treatment results in high-risk pediatric acute myeloid leukemia patients after intensification with high-dose cytarabine and mitoxantrone: results of Study Acute Myeloid Leukemia-Berlin-Frankfurt-Münster 93.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403932

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic factors in children and adolescents with acute myeloid leukemia (excluding children with Down syndrome and acute promyelocytic leukemia): univariate and recursive partitioning analysis of patients treated on Pediatric Oncology Group (POG)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403932

7 January 2021

based on heuristic

inferred from DOI database lookup

Attitudes of terminally ill cancer patients about euthanasia and assisted suicide: predominance of psychosocial determinants and beliefs over symptom distress and subsequent survival.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403932

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.LEU.2403932

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16136166

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16136166

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46681659&oldid=2125952299"